Literature DB >> 28825420

The dichotomy of T helper 17 cells in cancer.

Lekh N Dahal1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28825420     DOI： 10.1038/nri.2017.93

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  14 in total

1.  Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing.

Authors:  Karen Sandell Sfanos; Tullia C Bruno; Charles H Maris; Lauren Xu; Christopher J Thoburn; Angelo M DeMarzo; Alan K Meeker; William B Isaacs; Charles G Drake
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

Review 2.  The dichotomous nature of T helper 17 cells.

Authors:  Brigitta Stockinger; Sara Omenetti
Journal:  Nat Rev Immunol       Date:  2017-05-30       Impact factor: 53.106

3.  IL-23 promotes tumour incidence and growth.

Authors:  John L Langowski; Xueqing Zhang; Lingling Wu; Jeanine D Mattson; Taiying Chen; Kathy Smith; Beth Basham; Terrill McClanahan; Robert A Kastelein; Martin Oft
Journal:  Nature       Date:  2006-05-10       Impact factor: 49.962

4.  TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

Authors:  Mandy J McGeachy; Kristian S Bak-Jensen; Yi Chen; Cristina M Tato; Wendy Blumenschein; Terrill McClanahan; Daniel J Cua
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

5.  T helper 17 cells promote cytotoxic T cell activation in tumor immunity.

Authors:  Natalia Martin-Orozco; Pawel Muranski; Yeonseok Chung; Xuexian O Yang; Tomohide Yamazaki; Sijie Lu; Patrick Hwu; Nicholas P Restifo; Willem W Overwijk; Chen Dong
Journal:  Immunity       Date:  2009-10-29       Impact factor: 31.745

Review 6.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

7.  Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments.

Authors:  Ilona Kryczek; Mousumi Banerjee; Pui Cheng; Linhua Vatan; Wojciech Szeliga; Shuang Wei; Emina Huang; Emily Finlayson; Diane Simeone; Theodore H Welling; Alfred Chang; George Coukos; Rebecca Liu; Weiping Zou
Journal:  Blood       Date:  2009-05-21       Impact factor: 22.113

8.  Type 17 CD8+ T cells display enhanced antitumor immunity.

Authors:  Christian S Hinrichs; Andrew Kaiser; Chrystal M Paulos; Lydie Cassard; Luis Sanchez-Perez; Bianca Heemskerk; Claudia Wrzesinski; Zachary A Borman; Pawel Muranski; Nicholas P Restifo
Journal:  Blood       Date:  2009-05-26       Impact factor: 22.113

9.  The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans.

Authors:  Kellie A Charles; Hagen Kulbe; Robin Soper; Monica Escorcio-Correia; Toby Lawrence; Anne Schultheis; Probir Chakravarty; Richard G Thompson; George Kollias; John F Smyth; Frances R Balkwill; Thorsten Hagemann
Journal:  J Clin Invest       Date:  2009-09-08       Impact factor: 14.808

10.  IL17A-Mediated Endothelial Breach Promotes Metastasis Formation.

Authors:  Paulina Kulig; Sara Burkhard; Joanna Mikita-Geoffroy; Andrew L Croxford; Nadine Hövelmeyer; Gabor Gyülvészi; Christian Gorzelanny; Ari Waisman; Lubor Borsig; Burkhard Becher
Journal:  Cancer Immunol Res       Date:  2015-11-19       Impact factor: 11.151
View more
  2 in total

1.  Tumor-infiltrating IL-17A+ cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer.

Authors:  Zewei Wang; Quan Zhou; Han Zeng; Hongyu Zhang; Zhaopei Liu; Qiuren Huang; Ying Xiong; Jiajun Wang; Yuan Chang; Qi Bai; Yu Xia; Yiwei Wang; Yu Zhu; Le Xu; Bo Dai; Li Liu; Jianming Guo; Jiejie Xu
Journal:  Oncoimmunology       Date:  2020-04-10       Impact factor: 8.110

Review 2.  TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment.

Authors:  Zhenghou Zhang; Xiangyu Zhou; Jinshuai Guo; Fusheng Zhang; Yiping Qian; Guang Wang; Meiqi Duan; Yutian Wang; Haiying Zhao; Zhi Yang; Zunpeng Liu; Xiaofeng Jiang
Journal:  J Transl Med       Date:  2022-07-16       Impact factor: 8.440
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.